Discussion on "Estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie Davidian
Biometrics
.
2022 Sep;78(3):841-843.
doi: 10.1111/biom.13542.
Epub 2021 Sep 7.
Authors
Holly Janes
1
,
Fei Gao
1
,
Alex Luedtke
2
Affiliations
1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
2
Department of Statistics, University of Washington, Seattle, Washington, USA.
PMID:
34492117
PMCID:
PMC8653041
DOI:
10.1111/biom.13542
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
Randomized Controlled Trials as Topic
Vaccine Efficacy*
Grants and funding
DP2 LM013340/LM/NLM NIH HHS/United States
UM1 AI068635/AI/NIAID NIH HHS/United States
R56 AI143418/AI/NIAID NIH HHS/United States